Evidence map›Paper›PMID 32498436›Full record

ArticleJournal of fungi (Basel, Switzerland)2020

Clinical Usefulness of Susceptibility Breakpoints for Yeasts in the Treatment of Candidemia: A Noninterventional Study.

Cornelia Lass-Flörl, Robert Krause, Birgit Willinger, Peter Starzengruber, Petra Decristoforo, Sabrina Neururer, Peter Kreidl, Maria Aigner

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of fungi (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Cornelia Lass-FlörlInstitute of Hygiene and Medical Microbiology, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0002-2946-7785
Robert KrauseSection of Infectious Diseases and Tropical Medicine, Medical University of Graz, 8036 Graz, Austria.
Birgit WillingerDivision of Clinical Microbiology, Department of Laboratory Medicine, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0001-7921-5749
Peter StarzengruberDivision of Clinical Microbiology, Department of Laboratory Medicine, Medical University of Vienna, 1090 Vienna, Austria.
Petra DecristoforoInstitute of Hygiene and Medical Microbiology, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Sabrina NeururerDepartment of Medical Statistics, Informatics and Health Economy, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Peter KreidlInstitute of Hygiene and Medical Microbiology, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0001-8468-8719
Maria AignerInstitute of Hygiene and Medical Microbiology, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Innsbruck Medical University · ATMedical University of Vienna · ATMedical University of Graz · AT

Funding

Christian Doppler Forschungsgesellschaft CDL for Invasive Fungal Infections
6 · The paper itself

Abstract

This prospective noninterventional study evaluated whether antifungal susceptibility data (MIC) provided for

Indexed as

antifungal susceptibility testingCandida speciesclinical breakpointsin vitro versus in vivo outcomeMIC

Identifiers

PMID32498436
PMCPMC7345773
OpenAlexW3034143271

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.